Download App

Log in to access Online Inquiry
Company Overview More
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiovascular Portfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Medical Surgical Portfolio segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases. The Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The Diabetes Operating Unit segment offers insulin pumps and consumables, and continuous glucose monitoring systems. The company was founded in 1949 and is headquartered in Dublin, Ireland.
CEO: Martha, Geoffrey Straub
Market: NYSE
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

MDT Medtronic
103.550+1.020+0.99%
YOY
Do not show
Hide blank lines
(Q3)2022/01/28(Q2)2021/10/29(Q1)2021/07/30(FY)2021/04/30
Assets
Current assets
Cash, cash equivalents and short term investments
-23.35% 11.22B -25.27% 10.67B -18.58% 10.6B -1.2% 10.82B
-Cash and cash equivalents
-31.48% 3.48B -54.83% 2.9B -53.78% 3B -13.21% 3.59B
-Short-term investments
-19.03% 7.74B -1.12% 7.77B 16.55% 7.59B 6.11% 7.22B
Receivables
4.43% 5.45B 2.71% 5.49B 11.38% 5.43B 17.59% 5.46B
-Accounts receivable
4.43% 5.45B 2.71% 5.49B 11.38% 5.43B 17.59% 5.46B
Inventory
0.13% 4.51B -3.01% 4.35B -5.78% 4.29B 1.99% 4.31B
Other current assets
6.9% 2.12B 15.2% 2.22B 2.42% 2.12B -11.45% 1.96B
Total current assets
-11.55% 23.3B -12.69% 22.73B -8.47% 22.43B 2.35% 22.55B
Non current assets
Net PPE
4.54% 5.25B 5.06% 5.19B 5.74% 5.16B 8.14% 5.22B
-Gross PPE
5.45% 13.07B 6.39% 12.98B 7.16% 12.81B 9.07% 12.7B
-Accumulated depreciation
-6.07% -7.82B -7.3% -7.79B -8.15% -7.65B -9.73% -7.48B
Goodwill and other intangible assets
-4.9% 57.42B -2.5% 58.14B -1.3% 58.61B 1.35% 59.7B
-Goodwill
-1.89% 41.35B 0.97% 41.61B 2.47% 41.72B 5.32% 41.96B
-Other intangible assets
-11.85% 16.08B -10.26% 16.52B -9.53% 16.89B -6.94% 17.74B
Non current accounts receivable
-0.03% 3.31B 0.85% 3.2B 6.66% 3.19B 11.9% 3.17B
Other non current assets
13.99% 2.52B 18.32% 2.5B 12.41% 2.41B 16.67% 2.44B
Total non current assets
-3.41% 68.5B -1.18% 69.03B -0.04% 69.37B 2.73% 70.53B
Total assets
-5.62% 91.8B -4.31% 91.76B -2.24% 91.8B 2.64% 93.08B
Liabilities
Current liabilities
Payables
6.71% 2.37B 3.29% 2.38B 4.5% 2.21B 1.72% 2.54B
-accounts payable
9.31% 1.99B 0.79% 1.92B 8.37% 1.86B 5.51% 2.11B
-Total tax payable
-4.96% 383M 15.02% 467M -12.56% 341M -13.35% 435M
Current accrued expenses
-11.43% 3.54B -3.34% 3.47B 9.41% 3.65B 16.1% 3.48B
Current debt and capital lease obligation
-77.36% 865M -99.6% 16M -99.9% 6M -99.6% 11M
-Current debt
-77.36% 865M -99.6% 16M -99.9% 6M -99.93% 2M
-Current capital lease obligation
-- -- -- -- -- -- 80% 9M
Current liabilities
-28.78% 8.93B -35.36% 7.8B -40.67% 7.76B -17.91% 8.51B
Non current liabilities
Long term debt and capital lease obligation
-8.35% 24.29B -1.39% 25.61B 13.52% 25.96B 19.79% 26.38B
-Long term debt
-8.34% 24.23B -1.4% 25.55B 13.48% 25.9B 19.75% 26.32B
-Long term capital lease obligation
-10.77% 58M 5.36% 59M 33.33% 60M 37.78% 62M
Non current deferred liabilities
-21.43% 968M -18.15% 1.02B -14.38% 1.05B -12.44% 1.03B
Employee benefits
-32.96% 1.37B -25.64% 1.51B -22.48% 1.52B -18.48% 1.56B
Other non current liabilities
-19.62% 1.42B -8.29% 1.55B -1.19% 1.58B 5.65% 1.76B
Total non current liabilities
-10.78% 30.16B -5.09% 31.79B 6.57% 32.37B 11.96% 32.97B
Total liabilities
-15.65% 39.09B -13.11% 39.6B -7.65% 40.14B 4.18% 41.48B
Shareholders'equity
Share capital
-- 0 -- 0 -- 0 -- 0
-common stock
-- 0 -- 0 -- 0 -- 0
Retained earnings
5.68% 29.61B 5.26% 28.97B 2.49% 28.51B 1.64% 28.59B
Paid-in capital
-3.19% 25.81B -1.59% 26.06B -0.29% 26.18B 0.59% 26.32B
Gains losses not affecting retained earnings
26.59% -2.88B 20.84% -3.04B 15.15% -3.21B 2.11% -3.49B
Total stockholders'equity
3.51% 52.54B 3.64% 51.99B 2.37% 51.49B 1.36% 51.43B
Noncontrolling interests
0.59% 171M 10.53% 168M 21.09% 178M 28.89% 174M
Total equity
3.5% 52.71B 3.66% 52.16B 2.42% 51.66B 1.43% 51.6B
Currency Unit
USDUSDUSDUSD
Accounting Standards
US-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions
------Unqualified Opinion with Explanation

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%